86 related articles for article (PubMed ID: 16918135)
1. Comparison of dose distributions in IMRT planning using the gamma function.
Andenna C; Benassi M; Caccia B; Marzi S; Pedrini M; Zicari C
J Exp Clin Cancer Res; 2006 Jun; 25(2):229-34. PubMed ID: 16918135
[TBL] [Abstract][Full Text] [Related]
2. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric verification of intensity modulated radiation therapy of 172 patients treated for various disease sites: comparison of EBT film dosimetry, ion chamber measurements, and independent MU calculations.
Wilcox EE; Daskalov GM; Pavlonnis G; Shumway R; Kaplan B; VanRooy E
Med Dosim; 2008; 33(4):303-9. PubMed ID: 18973859
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric verification of brain and head and neck intensity-modulated radiation therapy treatment using EDR2 films and 2D ion chamber array matrix.
Varatharaj C; Ravikumar M; Sathiyan S; Supe SS; Vivek TR; Manikandan A
J Cancer Res Ther; 2010; 6(2):179-84. PubMed ID: 20622365
[TBL] [Abstract][Full Text] [Related]
5. Evaluation criteria for film based intensity modulated radiation therapy quality assurance.
Anjum MN; Parker W; Ruo R; Afzal M
Phys Med; 2010 Jan; 26(1):38-43. PubMed ID: 19620015
[TBL] [Abstract][Full Text] [Related]
6. Agreement criteria between expected and measured field fluences in IMRT of head and neck cancer: the importance and use of the gamma histograms statistical analysis.
De Martin E; Fiorino C; Broggi S; Longobardi B; Pierelli A; Perna L; Cattaneo GM; Calandrino R
Radiother Oncol; 2007 Dec; 85(3):399-406. PubMed ID: 17980925
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric quality assurance for intensity-modulated radiotherapy feasibility study for a filmless approach.
Wiezorek T; Banz N; Schwedas M; Scheithauer M; Salz H; Georg D; Wendt TG
Strahlenther Onkol; 2005 Jul; 181(7):468-74. PubMed ID: 15995841
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric verification of RapidArc treatment delivery.
Korreman S; Medin J; Kjaer-Kristoffersen F
Acta Oncol; 2009; 48(2):185-91. PubMed ID: 18777411
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
[TBL] [Abstract][Full Text] [Related]
10. VERIDOS: a new tool for quality assurance for intensity modulated radiotherapy.
Wiezorek T; Schwedas M; Scheithauer M; Salz H; Bellemann M; Wendt TG
Strahlenther Onkol; 2002 Dec; 178(12):732-6. PubMed ID: 12491063
[TBL] [Abstract][Full Text] [Related]
11. Gamma histograms for radiotherapy plan evaluation.
Spezi E; Lewis DG
Radiother Oncol; 2006 May; 79(2):224-30. PubMed ID: 16697065
[TBL] [Abstract][Full Text] [Related]
12. Study on surface dose generated in prostate intensity-modulated radiation therapy treatment.
Chow JC; Grigorov GN; Barnett RB
Med Dosim; 2006; 31(4):249-58. PubMed ID: 17134664
[TBL] [Abstract][Full Text] [Related]
13. Replacing pretreatment verification with in vivo EPID dosimetry for prostate IMRT.
McDermott LN; Wendling M; Sonke JJ; van Herk M; Mijnheer BJ
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1568-77. PubMed ID: 17394951
[TBL] [Abstract][Full Text] [Related]
14. 3D dose reconstruction for clinical evaluation of IMRT pretreatment verification with an EPID.
van Zijtveld M; Dirkx ML; de Boer HC; Heijmen BJ
Radiother Oncol; 2007 Feb; 82(2):201-7. PubMed ID: 17287039
[TBL] [Abstract][Full Text] [Related]
15. Comparison of IMRT treatment plans between linac and helical tomotherapy based on integral dose and inhomogeneity index.
Shi C; Peñagarícano J; Papanikolaou N
Med Dosim; 2008; 33(3):215-21. PubMed ID: 18674686
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Kodak EDR2 and Gafchromic EBT film for intensity-modulated radiation therapy dose distribution verification.
Sankar A; Ayyangar KM; Nehru RM; Kurup PG; Murali V; Enke CA; Velmurugan J
Med Dosim; 2006; 31(4):273-82. PubMed ID: 17134667
[TBL] [Abstract][Full Text] [Related]
17. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
[TBL] [Abstract][Full Text] [Related]
18. ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription.
Yaparpalvi R; Hong L; Mah D; Shen J; Mutyala S; Spierer M; Garg M; Guha C; Kalnicki S
Radiother Oncol; 2008 Dec; 89(3):347-52. PubMed ID: 18762345
[TBL] [Abstract][Full Text] [Related]
19. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer.
Krayenbuehl J; Davis JB; Ciernik IF
Radiother Oncol; 2006 Nov; 81(2):151-7. PubMed ID: 17055095
[TBL] [Abstract][Full Text] [Related]
20. The next step in patient-specific QA: 3D dose verification of conformal and intensity-modulated RT based on EPID dosimetry and Monte Carlo dose calculations.
van Elmpt W; Nijsten S; Mijnheer B; Dekker A; Lambin P
Radiother Oncol; 2008 Jan; 86(1):86-92. PubMed ID: 18054102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
